The human IGF2 gene belongs to a group of imprinted genes clustered on the short arm of chromosome 11, band p15.5. It contains 9 exons and spans over 30 kb. IGF2 mRNA overexpression has been reported in human tumours and in some inherited growth disorders. It was recently demonstrated that IGF2 mRNA overexpression contributes to tumour progression and that loss of parental imprinting as well as altered transcription factors are contributing to this overexpression. We have reported structural alterations in the 3' region of the IGF2 gene in two colorectal tumours that overexpressed the IGF2 transcript by 200-and 800-fold. We cloned by the vectorette-PCR strategy, genomic DNA fragments containing the breakpoints from these tumours. The sequencing of these fragments positioned the breakpoint 2 kb downstream the IGF2 gene in one tumour, and in exon 9 in the second. Both breakpoints occurred in regions containing repetitive elements: a TGGA repeat we have identi®ed downstream the gene, and the (CA)n repetition in exon 9. We hypothesize that a negative regulatory element, located downstream the IGF2 gene, has been deleted following these structural alterations and leads to IGF2 gene overexpression.
Introduction
Insulin-like growth factor 2 (IGF2) is a polypeptidic growth factor with structural homologies to IGF1 and pro-insulin (Daughaday and Rotwein, 1998) . IGF2 is produced mainly by the liver, but local IGF2 secretion has been reported in most human adult tissues (Humbel, 1990) . IGFs control cell proliferation, dierentiation and death. They exert their biological activities mainly through the IGF1 receptor, a receptor with tyrosine kinase activity, highly homologous to the insulin receptor. At high concentrations, IGF2 can also bind and activate the insulin receptor. IGF2 binds the IGF2 receptor, also known as the mannose-6-phosphate receptor, which does not seem to have any IGF signalling function. Moreover, at least seven IGF binding proteins (IGFBPs) can bind IGF2 with high anity and modulate its biological activities (Jones and Clemmons, 1995) . Cellular IGF2 production is controlled at the levels of gene transcription and translation. The gene is a complex transcription unit, containing nine exons, four promoters (P1 to P4) and two polyadenylation sites. Five transcripts are synthesized, containing dierent 5' untranslated regions (UTR), a common coding region, and two dierent 3' UTRs. The expression of the gene is under development and cell speci®c control. P1 is active in the adult liver, P3 and P4 in most foetal tissues and the extrahepatic adult tissues while P2 activity has only been detected in some cancer cell lines . Moreover, IGF2 gene expression is submitted to parental imprinting, only the paternal allele being expressed in most healthy adult tissues (Giannoukakis et al., 1993) . The IGF2 mRNAs are translated with dierent eciencies, depending on the promoter and hence on the 5' untranslated region they contain. In general, the transcript initiated at promoter P3 is less eciently translated than the others (de Moor et al., 1994) .
IGF2 mRNA overexpression has been reported in human tumours, i.e. leiomyosarcomas (Daughaday et al., 1988) , hepatomas (Ishida et al., 1995), rhabdomyosarcomas (Minniti and Helman, 1994) , Wilms' tumours (Reeve et al., 1985) and some inherited growth disorders notably the Beckwith-Wiedemann syndrome (Reeve et al., 1985; Sun et al., 1997) . It was recently demonstrated, in transgenic mice systems, that IGF2 mRNA overexpression contributes to tumour progression (Christofori et al., 1994; Rogler et al., 1994) . Loss of parental imprinting as well as altered transcription factors are contributing to this overexpression in tumours (Toretsky and Helman, 1996) .
We have detected IGF2 mRNA overexpression in 30% of colon cancers. Interestingly, in two of the tumours, T11 and T18, where the overexpression was exceptionally high, the IGF2 gene was rearranged (Lambert et al., 1990) . We mapped and characterized the breakpoints which occurred in these tumours, in order to understand if sequences located downstream the IGF2 gene could in¯uence its expression.
In DNA from one of the colorectal tumours (T11), we previously detected an additional EcoRI* restriction site approximately 500 bp upstream the EcoRI site of the normal IGF2 allele (Figure 1a ) (Lambert et al., 1990) . A T11/EcoRI vectorette library (Arnold and Hodgson, 1991) was constructed from T11 genomic DNA and PCR-ampli®ed successively with primers p1+ and vectorette, then with primers p2+ and vectorette ( Figure 1a ). Two fragments of 4.2 kb (A) and 3.7 kb (B), corresponding to the expected sizes of the normal and rearranged fragments were obtained (Figure 1b ). They were cloned and sequenced. Sequences of fragments A and B were aligned with that of the known sequence downstream the IGF2 gene, ending 571 bp downstream of the p2+ primer (Ellsworth et al., 1994) (Figure 1c ). Both clones A and B contained this sequence. The identity between both clones continued until position 937 after which the sequences diverged. This positioned the breakpoint 2021 bp downstream the polyadenylation signal at the 3' end of exon 9. Since the EcoRI* site was located upstream the normal EcoRI site, fragment B should originate from the rearranged allele.
The analysis of fragment A with the RepeatMasker software in order to detect repetitive elements in the (Figure 1c ). The breakpoint occurred in fragment B in one of these (TGGA)n repeats. The downward sequence contained fragments of Short and Long Interspersed Elements (SINES and LINES) (Smit, 1996) separated by short non-repetitive elements ( Figure 1c ). These non-repetitive sequences did not show any signi®cant homology with other known sequences.
We veri®ed the actual presence of the hybrid from clone B in T11 genomic DNA. Genomic DNAs from T11 and from white blood cells from ®ve healthy blood donors were hydrolyzed with RsaI, which should generate fragments of dierent lengths due to the dierent location of the downstream RsaI restriction sites in clones A and B (Figure 1d ). The Southern blot was hybridized with a probe recognizing the 5' end of fragments A and B (Figure 1d) . A 4 kb hybridizing band, originating from the normal allele (1), was detected in all the samples while a 1.4 kb fragment, originating from the altered allele (2), was exclusively detected in T11 genomic DNA ( Figure 1e ). In addition, PCR ampli®cation of T11 genomic DNA with primers surrounding the breakpoint gave rise to a fragment with a restriction pro®le identical to that of fragment B (data not shown). These results con®rmed that T11 genomic DNA actually contained the breakpoint found in fragment B.
In T18, two additional HindIII* restriction sites had been located previously by Southern blot within and about 10 kb downstream of exon 9 (Figure 2a ), indicating that T18 harboured two altered IGF2 alleles (Lambert et al., 1990) . The allele T1, containing the HindIII* restriction site within the ninth exon was cloned. A T18/HindIII vectorette library was ampli®ed ®rst with primers p3+ and vectorette, then with primers p4+ and vectorette (Figure 2a) . A single 1.6 kb fragment Figure 3 Identi®cation of the IGF2 alleles in T18 and H18. (a) Determination of the ApaI RFLP and of the (CA)n repeat length polymorphism status. Ampli®cation with p5+ and p17 gives rise to a 2.2 kb fragment containing the ApaI polymorphic restriction site. Ampli®cation with p4+ and p17 primers generates a fragment of about 800 bp containing the (CA)n polymorphic length repetition. (b) Analysis of the ApaI polymorphism of the PCR fragments ampli®ed with p5+ and p17 primers. pBluescript DNA was used as a control of completion of the ApaI digestion. Lanes: 1: molecular weight marker; 2: ApaI-restricted PCR fragment from the T18 DNA sample; 3: ApaI-restricted PCR fragment from the H18 DNA sample; 4: circular pBluescript; 5: PCR-ampli®ed fragment from the T18 DNA sample; 6: PCR-ampli®ed fragment from the H18 DNA sample. (b: ApaI-restricted pBluescript; u: uncut PCR fragment: c: cut PCR fragment). (c) Analysis of the (CA)n length polymorphism of the PCR fragments ampli®ed with p4+ and p17 primers on a 4% Nusieve agarose gel. Lanes: 1: PCR ampli®cation from the T18 DNA sample; 2: PCR ampli®cation from the H18 DNA sample; 3: molecular weight marker. (d) Separation of the normal (20.5 kb) and the rearranged (17.5 kb) HindIII fragments from T18 genomic DNA. HindIII-restricted T18 genomic DNA was run in duplicate on a 0.7% agarose gel. The left of the gel was transferred to a nylon membrane and hybridized. The detected hybridization bands were located on the right part of the agarose gel to allow separate gel extraction of both fragments. (e) PCR analysis of the (CA)n length polymorphism of the 20.5 kb and 17.5 kb HindIII fragments with p4+ and p17 primers on 4% Nusieve agarose gel. Lanes: 1: PCR ampli®cation of the rearranged allele; 2: PCR ampli®cation of the normal allele; 3: ampli®cation of total T18 genomic DNA; 4: molecular weight marker. (f) Identi®cation of the ApaI polymorphism in the allele rearranged in exon 9. PCR ampli®cation was carried out with primers p5+ and pr27, the latter being derived from the sequence downstream the breakpoint cloned in exon 9. (g) Ethidium bromide stained gel containing the ampli®ed fragments. Lanes: 1 and 5 molecular weight marker; 2: undigested PCR fragment (2.8 kb): 3: mixture of the PCR ampli®ed fragment and pBluescript digested with ApaI. The white arrows indicate the digestion products; 4: undigested pBluescript (Figure 2b) , cloned and sequenced. It was aligned with the corresponding sequence of exon 9 beginning with primer p4+. The breakpoint in clone C was located at position 699, inside the (CA)n dinucleotide repeat of exon 9. The sequence downstream from the breakpoint was composed of an interrupted AluY sequence followed by two distinct fragments originating from dierent L1 sequences (Figure 2c) . We veri®ed the actual presence of the hybrid sequence of fragment C in T18 genomic DNA. A Southern blot containing AccIrestricted T18 and healthy tissue (H18) genomic DNA was hybridized with a probe covering the region comprised between exon 7 and the beginning of exon 9 (Figure 2d) . The expected 5.3 kb fragment was detected in both tissues. Only T18 DNA contained the expected 2.6 kb additional band (Figure 2e ). The presence of the other higher molecular weight hybridizing bands was probably due to the sensitivity of AccI to methylation. Figure 4 Identi®cation of the expressed alleles in H18 and T18. (a) Positions of p6+, p4+ and p17 primers used for the RT ± PCR ampli®cations of cDNA fragments containing the ApaI and the (CA)n polymorphisms. (b) Analysis of the ApaI polymorphism in IGF2 alleles of T18 and H18. pBluescript circular plasmid was used to control the completion of the ApaI hydrolysis. Lanes: 1: molecular weight marker; 2: ApaI digested RT ± PCR fragment from T18 mixed with pBluescript. 3: ApaI digested RT ± PCR fragment from H18 mixed with pBluescript. 4: undigested pBluescript. 5: undigested RT ± PCR fragment from T18 (2.0 kb). 6: undigested RT ± PCR fragment from H18. (c) Analysis of the (CA)n polymorphisms of H18 and T18 expressed alleles. Lanes: 1: RT ± PCR ampli®cation from H18 total RNA; 2: RT ± PCR ampli®cation from T18 total RNA; 3: molecular weight marker. (d) Summary of the results: H18 contained two distinct alleles (H1 and H2) expressed at low levels (thin arrows). Allele H2 underwent two dierent rearrangements in T18, giving rise to the allele broken in exon 9 (T1) and to the allele broken downstream the gene (T2). Overexpression originated from the allele containing the ApaI restriction site and a small (CA)n repeat that corresponded to allele T2. Any putative hybrid mRNA from allele T1 could be detected (data not shown), but the 2.2 kb mRNA, originating from the ®rst polyadenylation site that is located upstream the breakpoint detected in exon 9, was strongly expressed in T18 in comparison to T11
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The presence of the breakpoint in T18 genomic DNA was further con®rmed by PCR ampli®cation of fragments having the correct sizes with several pairs of primers surrounding the breakpoint (data not shown). Taken together, these results unambiguously con®rmed the existence of breakpoints in the (TGGA)n repeat we identi®ed downstream the IGF2 gene for T11, and in the (CA)n dinucleotide repeat inside exon 9 for T18.
The IGF2 gene expression is monoallelic in most healthy tissues, only the paternal allele being expressed. Thus, in order to ®nd out if the overexpression is related to the rearrangement, we identi®ed the overexpressed allele. The IGF2 alleles of T11, T18 and H18 were distinguished using the ApaI RFLP (Schneid et al., 1992) and the (CA)n repeat length polymorphism (Rainier et al.,1993) in the transcribed region of the gene. The genomic DNAs were PCR-ampli®ed with primers p5+ (exon 8) and p17 (exon 9) surrounding the region containing these polymorphisms (Figure 3a ). T18 and H18 DNAs were heterozygous for the ApaI RFLP since only half of the ampli®ed PCR fragments were cleaved (Figure 3b ). The region containing the (CA)n repeat was PCR ampli®ed with primers p4+ and p17 (Figure 3a) . Two polymorphic fragments ampli®ed from T18 and H18 DNAs were detected on a 4% Nusieve agarose gel (Figure 3c ). For T11, neither of the ApaI and (CA)n polymorphisms were informative.
We next identi®ed the polymorphism present in each of the three IGF2 alleles of T18 (Figure 2a) . First, the HindIII hydrolyzed T18 genomic DNA was submitted to electrophoresis. The 20.5 kb fragment (T3, Figure  2a ) originating from the normal allele and the 17.5 kb fragment (T2, Figure 2a ) originating from the allele that was rearranged downstream the end of exon 9, were separately puri®ed from an agarose gel ( Figure  3d ) and PCR-ampli®ed with primers p4+ and p17. The results (Figure 3e) showed that the rearranged allele T2 contained the short (CA)n repeat. Thereafter, the second rearranged T18 allele (T1, Figure 2a) , broken inside exon 9, was ampli®ed with primers p5+ and pr27 that surround the cloned breakpoint ( Figure  3f ). The ampli®ed fragment was fully hydrolyzed by ApaI (Figure 3g) .
We next analysed the same polymorphisms from RT ± PCR ampli®ed total cellular RNAs of T18 and H18 using p6+ (exon 7) and p17 primers (Figure 4a) . Unexpectedly, the transcription was biallelic in H18 but monoallelic in T18. Moreover, the unique expressed allele in T18 contained the ApaI restriction site (Figure 4b ) and the short (CA)n repeat (Figure 4c ) indicating that the latter polymorphism was associated with the ApaI restriction site. Figure 4d summarizes these results. H18 thus harbours two polymorphic alleles. Allele H1 contains the long (CA)n repeat while allele H2 contains the short (CA)n repeat that was shown to be associated to the ApaI restriction site. Both alleles were expressed indicating loss of parental imprinting of the gene. Since we showed that the ApaI site was present in allele T1 (Figure 3g ) and that allele T2 contained the small (CA)n repeat (Figure 3e) , both T1 and T2 rearranged alleles originated from the H2 allele (Figure 4d) . Moreover, we showed that, in T18, the overexpression occurred from the allele containing the ApaI site associated to the small (CA)n repeat. This corresponded to allele T2 containing the rearrangement downstream the IGF2 gene. This de®nitely proves that structural alterations downstream of the IGF2 gene are associated with overexpression of the gene.
To our knowledge, this is the ®rst report describing the precise location of breakpoints in and downstream of the IGF2 gene in tissues expressing very high levels of the IGF2 transcripts. Both breakpoints occurred in repetitive sequences of which a long stretch of (TGGA)n repeat, which also displayed length polymorphism (data not shown), was pointed out downstream the IGF2 gene. Cytogenetic studies have described translocations in the vicinity of the IGF2 gene in Wilms' tumours (Karnik et al., 1998 ), rhabdomyosarcomas (Besnard-GueÂ rin et al., 1996 , breast tumours (Winqvist et al., 1995) , stomach adenocarcinomas (Baa et al., 1996) , as well as in the Beckwith-Wiedemann syndrome (Mannens et al., 1994) . However, IGF2 mRNA levels were not measured in these reports. Irminger et al. (1989) located a breakpoint in the 3' region of the IGF2 gene in a Wilms' tumour containing very high levels of the IGF2 transcript.
These results allow us to hypothesize the presence of a negative regulatory element downstream of the IGF2 gene. This could explain the low level of IGF2 expression detected in the majority of adult tissues. Following the rearrangement event, the disappearance of this regulator would lead to the overexpression of the gene. The disappearance of a negative regulator of IGF2 gene expression has been proposed by others to explain the very high levels of IGF2 transcripts in some tumours (Fidler et al., 1992; Gicquel et al., 1995) . This, in addition to loss of parental imprinting or loss of heterozygocity, might represent a novel mechanism of IGF2 gene overexpression.
Materials and methods

Tissues
The tissues, DNA and RNA extractions were described previously (Lambert et al., 1990 GCGGGGAGAGCCAGTGTTGAAGTGA, (Life Technologies) Primers p2+ and p37 were used to amplify a 386 bp fragment that was used as a probe for the hybridization of the Southern blot in Figure 1e . The probe used to hybridize the Southern blot in Figure 2e was a HindIII-SacI genomic DNA fragment. DNA fragments were radiolabelled with a 32 P-dCTP (4000 Ci/mmol, ICN, Costa Mesa, CA, USA) using the Ready-to-go (Amersham/Pharmacia) DNA labelling kit.
Vectorette libraries
One mg of T11 and T18 genomic DNA were microdyalized and restriction digested with EcoRI (Boehringer Mannheim, Germany) and HindIII (Boehringer), respectively, for 1 h at 378C in a ®nal 50 ml reaction volume. Five ml (3 pmol) of compatible vectorettes (Genosys, UK), 1 ml of T4 DNA ligase (Boehringer) and 6 ml of ligase buer were added. The mixture was incubated at 208C for 60 min followed by two further cycles of incubation at 378C for 30 min and at 208C for 60 min in order to maximize ligation of vectorette to restricted DNA fragments. Two hundred ml of sterile water were added and the libraries (T11/EcoRI and T18/HindIII) stored at 7208C in 20 ml aliquotes until use.
Long-PCR ampli®cation
Expand (Boehringer) or Elongase (Life Technologies) Taq polymerase mixes were used. dNTPs (10 mM), primers (10 pmol) and speci®c PCR buers with dierent dilutions of vectorette libraries (4 ng to 4 pg) were mixed in a ®nal volume of 50 ml following the recommendation of the manufacturers. DNA was predenatured for 1 min at 948C, denatured at 948C for 1 min, annealed to primers for 30 s at the optimal temperature for the primers that were used and extended at 688C for 1 min by kb to amplify. Thirty to thirty®ve cycles were carried out in a PTC-200 thermal cycler (MJ Research). For the nested-PCR, 1 ml of the ®rst PCR ampli®cation was used as a template in the next reaction. After completion of the reaction, PCR products were analysed on a 1% agarose gel.
Cloning of the PCR products T11 and T18 PCR products were cloned with the TA cloning kit (Stratagene, La Jolla, CA, USA) and Topo cloning kit (Stratagene) respectively, following the recommendations of the manufacturer.
Sequencing
Sequencing was performed by Eurogentec (Liege, Belgium). Clone B was entirely sequenced but subcloning was necessary to obtain satisfactory sequencing signals. The sequencing signal obtained from clone A decreased dramatically and Erase-a-Base was necessary to achieve the reading of a central 2 kb sequence of this clone.
Southern blots
T11, T18, H18 and lymphocytes genomic DNA were restricted, ethanol-precipitated, washed and dissolved in Tris-HCl 10 mM, pH 8. Restricted DNA was run on a 1% agarose gel and vacuum transferred to nylon membranes (Zetaprobe, Biorad) following the recommendations of the manufacturer. Membranes were hybridized, washed and revealed by autoradiography and by Phosphorimager analysis (Molecular Dynamics).
RT ± PCR
One mg of T18 or 5 mg of H18 total RNA were reverse transcribed with 50 pmoles of the p1-primer, located downstream the (CA)n repeat of exon 9, using the`Expand Reverse Transcriptase' Kit (Boehringer Mannheim) following the recommendations of the manufacturer. PCR was carried out with primers p6+ (exon 7) and p17 with thè Expand Long PCR system' (Boehringer). The ampli®ed band was excised and puri®ed from the agarose gel (Qiagen, Germany) to avoid any genomic DNA contamination in the subsequent PCR ampli®cations of the (CA)n repeats form exon 9.
The sequences have been submitted to GenBank and have the following accession numbers: A: Banklt247182 AF119357; B: Banklt247246 AF119358; C: Banklt247249 AF119359.
